II. Background: Altitudes
- See FIO2 and PiO2 at Altitude
- Low Altitude: <1500 meters (<4900 feet)
- High Altitude: 1500 to 3500 meters (4900 to 11500 feet)
- Most common elevations for Acute Mountain Sickness: 2500 to 3500 meters (8200 to 11482 feet)
- Affects the greatest number of people exposed who ascend quickly (e.g. travel to alpine city)
- Colorado Ski Resorts: Affects 25% of travelers
- Himalayas: Affects 50% of travelers
- Very High Altitude: 3500 to 5500 meters (11500 to 18000 feet)
- Blood Oxygen Saturation <90% even in health persons
- Associated with severe Acute Mountain Sickness (as well as HACE and HAPE)
- Affects 25% who climb to this altitude
- Extreme Altitude: >5500 meters (>18000 feet)
- Significant Hypoxia and hypercarbia
- Affects 50% who climb above 6000 meters
III. Pathophysiology: Mechanism
- See FIO2 and PiO2 at Altitude
- Acclimitization to altitude occurs over days to weeks and decreases the risk of High Altitude Illness
- Sleep and Exercise tolerance improve after acclimitization
- Initial response to altitude is hypoxic Ventilatory response
- Increased Respiratory Rate and Minute Ventilation
- Effect is tempered by carbon dioxide levels that fall, resulting in Respiratory Alkalosis
- Respiratory Alkalosis results in decreased respiratory drive
- Respiratory Alkalosis is compensated over 48 hours by increased renal bicarbonate
- Cardiovascular response (Sympathetic Nervous System)
- Increased Heart Rate, venous tone and Cardiac Output
- Pulmonary Hypertension results from Hypoxemia response
- Risk of High Altitude Pulmonary Edema (HAPE) in severe Pulmonary Hypertension
- Cerebral Blood Flow results from Hypoxemia response
- Risk of High Altitude Cerebral Edema (HACE) in disordered autoregulation of cerebral Hypertension
- Erythropoietin released from Kidney as Hypoxemia response
- Increases Red Blood Cell production and oxygen carrying capacity
- Hypobaric Hypoxemia results in paradoxical and maladaptive physiologic changes at altitude (>1500 meters)
- Hypoxic stress due to lower barometric pressure and less available oxygen (decreased PiO2 and FIOO2)
- Symptom onset may begin within 6-12 hours of ascent
- Fluid retention
- Contrast with non-affected persons at altitude who experience diuresis
- Changes at altitude that may exacerbate comorbid illness
- Low Partial Pressure of oxygen
- Increased sympathetic tone
- Pulmonary artery Vasoconstriction
- Increased Systemic Vascular Resistance
IV. Types: High Altitude Illness
- Acute Mountain Sickness
- High Altitude Cerebral Edema (HACE)
- High Altitude Pulmonary Edema (HAPE)
V. Risk Factors
- Rapid ascent (as opposed to gradual acclimatization)
- Very high altitude
- Significant physical exertion
- Prior history of altitude sickness
- Traveling from low altitude
- Prolonged time at altitude
- Genetic susceptibility
- Younger age
- Aside from comorbidity, older adults may be less affected by altitude
- Substances increasing High Altitude Illness risk (decrease hypoxic Ventilatory response)
VI. Symptoms
- See High Altitude Cerebral Edema (HACE)
- See High Altitude Pulmonary Edema (HAPE)
- Common Symptoms
- Other Symptoms
VII. Course
- Onset: 6-12 hours following high altitude ascent
VIII. Diagnosis
IX. Differential Diagnosis
- Viral illness
- Alcohol-related Hangover
- Heat Exhaustion
- Dehydration
- Hypothermia
- Hypoglycemia
- Hyponatremia
- Medication: Sedative or hypnotic
- Carbon Monoxide Poisoning (e.g. cooking in tent)
X. Management
- Very mild symptoms may resolve spontaneously with acclimitization
- Immediate descent (at least 1000 feet or 300 meters) is most critical for moderate to severe symptoms
- Other measures for moderate to severe symptoms where descent is not immediately possible
- Supplemental Oxygen to keep Oxygen Saturation >90%
- Acetazolamide 250 mg orally twice daily
- Dexamethasone 4 mgPO/IV/IM every 6 hours
- Gamow Bag (Portable Hyperbaric Chamber)
- Other measures
- Antiemetics (e.g. Zofran) for Nausea, Vomiting
- Acetaminophen or Ibuprofen for Headache
XI. Complications (0.1 to 4 percent Incidence)
- See Pathophysiology above
- Altitudes above 11,400 feet (3500 meters) are associated with a more complicated course
- High Altitude Pulmonary Edema (HAPE)
- High Altitude Cerebral Edema (HACE)
XII. Prevention
- Medication Prophylaxis
- Indications
- Travel to 11,000 feet in one day (or over 9,000 feet if history of prior altitude sickness)
- Acetazolamide (Diamox)
- Adults: 125 mg every 12 hours (FDA approved)
- Up to 250 mg twice daily may be used (but 125 mg is typically sufficient)
- Children: 2.5 mg/kg up to 125 mg every 12 hours (off-label)
- Start 1 day or more before ascent
- Continue until acclimitization to the highest sleeping altitude (approximately 2 days)
- Adults: 125 mg every 12 hours (FDA approved)
- Dexamethasone
- Dose: 4 mg orally every 12 hours, or 2 mg every 6 hours (not FDA approved)
- Alternative, in those who cannot take Acetazolamide
- Some Wilderness Medicine experts recommend limiting Dexamethasone for treatment (not prophylaxis)
- Risk of rebound mountain sickness when discontinued
- May require taper with prolonged use (risk of adrenal suppression)
- Does not speed acclimitization, but does reduce symptoms
- Additional mild symptom management (severe symptoms require immediate descent)
- Acetaminophen
- Ibuprofen 600 mg every 8 hours
- May have a prophylactic role (limited evidence)
- Indications
-
General Pointers
- Gradual ascent to allow for acclimitization is the most important single preventive factor
- Recognize the symptoms of Acute Mountain Sickness
- Never ascend to sleep higher if you have symptoms
- Descend if symptoms do not resolve or worsen
- Never leave a person with altitude sickness alone
- Maintain hydration
- Avoid overexertion
- Avoid Alcohol and Sedatives
- For altitudes above 9800 feet (3000 meters)
- Recommended ascent rate <1000 feet/day (300 meter/day)
- Spend an additional rest day if ascent over 2000 feet (600 meters)
- Do not sleep >2000 feet (600 meters) higher than the night before
- Comorbid Conditions
- See Air Travel Restriction
- Patients with asymptomatic cardiopulmonary disease may ascend safely to at least 8200 feet (2500 meters)
- Conditions which absolutely contraindicate high altitude travel
- Severe Chronic Obstructive Pulmonary Disease (COPD)
- Uncontrolled Congestive Heart Failure (CHF)
- Conditions for which caution should be Exercised due to risk of exascerbation (emphasize acclimitization)
- Arrhythmias
- Coronary Artery Disease
- Hypertension
- Sickle Cell Anemia (splenic infarct risk increases above 4900 feet (1500 meters)
- Keep Supplemental Oxygen available
XIII. References
- (2018) Presc Lett 25(2)
- Candy and Contant in Herbert (2020) EM:Rap 20(3): 3-4
- Comp and Rogich (2021) Crit Dec Emerg Med 35(4): 3-8
- Basnyat (2003) Lancet 361(9373): 1967-74 [PubMed]
- Fiore (2010) Am Fam Physician 82(9): 1103-10 [PubMed]
- Hackett (2001) N Engl J Med 345(2): 107-14 [PubMed]